Dietary Supplement Listing Act of 2026

This bill would require every dietary supplement sold in the United States to be listed with the Food and Drug Administration (FDA). The company named on the label would have to submit information such as the product name, label copy, ingredients and amounts, servings, directions, warnings, allergens, and health claims. The FDA would assign each product a listing number that must appear on the label, and within 2 years would create a public, searchable online database of most listing information, while keeping some details confidential, such as amounts in proprietary blends. Products whose makers fail to meet the listing rules would be considered misbranded. The bill authorizes about $7.9 million for 2026 and $6.6 million per year for 2027 through 2030.

Full text and official record on Congress.gov

Sponsors

• Maxine Dexter Democrat sponsor
• 0 cosponsors